IL315333A - A continuous dosing regimen to treat the condition of the eye - Google Patents

A continuous dosing regimen to treat the condition of the eye

Info

Publication number
IL315333A
IL315333A IL315333A IL31533324A IL315333A IL 315333 A IL315333 A IL 315333A IL 315333 A IL315333 A IL 315333A IL 31533324 A IL31533324 A IL 31533324A IL 315333 A IL315333 A IL 315333A
Authority
IL
Israel
Prior art keywords
eye
treatment
condition
dosing regimen
continuous dosing
Prior art date
Application number
IL315333A
Other languages
English (en)
Hebrew (he)
Inventor
Said Saim
Dario Paggiarino
Owen N Durham
Nancy Lurker
Jay S Duker
Michelle Howard-Sparks
Basel Karzoun
Original Assignee
Eyepoint Pharmaceuticals Inc
Said Saim
Dario Paggiarino
Owen N Durham
Nancy Lurker
Jay S Duker
Howard Sparks Michelle
Basel Karzoun
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eyepoint Pharmaceuticals Inc, Said Saim, Dario Paggiarino, Owen N Durham, Nancy Lurker, Jay S Duker, Howard Sparks Michelle, Basel Karzoun filed Critical Eyepoint Pharmaceuticals Inc
Publication of IL315333A publication Critical patent/IL315333A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL315333A 2022-03-11 2023-03-10 A continuous dosing regimen to treat the condition of the eye IL315333A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263318823P 2022-03-11 2022-03-11
US202263320984P 2022-03-17 2022-03-17
US202263341456P 2022-05-13 2022-05-13
US202263390051P 2022-07-18 2022-07-18
PCT/US2023/064148 WO2023173093A1 (en) 2022-03-11 2023-03-10 Continuous dosing regimen for treatment of a condition of the eye

Publications (1)

Publication Number Publication Date
IL315333A true IL315333A (en) 2024-10-01

Family

ID=85937358

Family Applications (1)

Application Number Title Priority Date Filing Date
IL315333A IL315333A (en) 2022-03-11 2023-03-10 A continuous dosing regimen to treat the condition of the eye

Country Status (9)

Country Link
US (1) US20250186398A1 (enExample)
EP (1) EP4489750A1 (enExample)
JP (1) JP2025507154A (enExample)
KR (1) KR20240156416A (enExample)
AU (1) AU2023230976A1 (enExample)
CA (1) CA3245209A1 (enExample)
IL (1) IL315333A (enExample)
TW (1) TW202400143A (enExample)
WO (1) WO2023173093A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20240329A1 (es) 2019-06-05 2024-02-27 Regeneron Pharma Dispositivos y metodos para administracion de dosis de precision
SI4210682T1 (sl) * 2020-09-14 2026-07-31 EyePoint, Inc. Bioerozibilni očesni vložek za dovajanje zdravil in terapevtska metoda
US12649031B2 (en) 2021-09-08 2026-06-09 Regeneron Pharmaceuticals, Inc. Methods for delivering agents with pre-filled syringes to minimize intraocular inflammation
USD1120314S1 (en) 2022-11-30 2026-03-24 Regeneron Pharmaceuticals, Inc. Dose delivery device

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008033562A2 (en) 2006-09-15 2008-03-20 Xcovery, Inc. Kinase inhibitor compounds
SG11201901962QA (en) 2016-09-29 2019-04-29 Equinox Sciences Llc Polymorphic form of kinase inhibitor compound, pharmaceutical composition containing same, and preparation method therefor and use thereof
CA3066437A1 (en) * 2017-06-13 2018-12-20 EyePoint Pharmaceuticals, Inc. Bioerodible drug delivery devices
US20210340516A1 (en) * 2020-04-29 2021-11-04 Augusta University Research Institute, Inc. Compositions containing arginase 1 for the treatment of neurovascular and retinal vascular disorders
SI4210682T1 (sl) * 2020-09-14 2026-07-31 EyePoint, Inc. Bioerozibilni očesni vložek za dovajanje zdravil in terapevtska metoda

Also Published As

Publication number Publication date
WO2023173093A9 (en) 2023-12-07
WO2023173093A1 (en) 2023-09-14
EP4489750A1 (en) 2025-01-15
US20250186398A1 (en) 2025-06-12
TW202400143A (zh) 2024-01-01
CA3245209A1 (en) 2023-09-14
KR20240156416A (ko) 2024-10-29
JP2025507154A (ja) 2025-03-13
AU2023230976A1 (en) 2024-09-19

Similar Documents

Publication Publication Date Title
SI3681500T1 (sl) Uporaba pilokarpinijevega hidroklorida za zdravljenje presbiopije
IL291642A (en) Heteroaryl-biphenyl amides for the treatment of pd-l1 diseases
IL289402A (en) A medical device container
GB201910469D0 (en) Baffle for use with a treatment machine
CA201950S (en) Medicament container
PL4039603T3 (pl) Pojemnik typu wielopak i maszyna do jego produkcji
HUE066404T2 (hu) Eljárások csomagolt, a csomagolásban hidratált, hidrofil gyógyászati termékek elõállítására
SMT202400240T1 (it) Macchina di avvolgimento per stiramento con controllo di adattamento di curva di tasso di erogazione.
SG11202011680YA (en) Dosing regimen for the treatment of pi3k related disorders
PT4058148T (pt) Regime de dosagem para agentes anti-bcma
CA192342S (en) Packaging machine
LT3949971T (lt) Liuteolin-7-o-gliukozido arba liuteolin-7-o-gliukuronido panaudojimas vaisto, skirto akių pažeidimamas gydyti, gamyboje
GB2575304B (en) Medicament packaging arrangements
CA190218S (en) Diaper container
CA187420S (en) Tortilla packaging container
IL288797A (en) Treatment of synoclinopathy
PL3549447T3 (pl) Maszyna do formowania ciasta do wyrobów pieczonych w piekarniku
SG11202112312PA (en) Multilumen body for a medical device
SI4072532T1 (sl) Dozirna oblika za uporabo v zdravljenju ali preprečevanju bolezni
EP4028126C0 (en) TREATMENT OF NEUROLOGICAL DISEASE WITH COMPLEMENT INHIBITORS
SG10201907758XA (en) A self-releasable safety belt
PL3725774T3 (pl) Sposób wytwarzania środka farmaceutycznego
IL288972A (en) A continuous process for the preparation of anticholinergic drugs
GB202314365D0 (en) Medical packaging
GB202314366D0 (en) Medical packaging